Nakase Hiroshi, Herfarth Hans
Department of Gastroenterology and Hepatology, Division of Endoscopy, Kyoto University Hospital, Kyoto, Japan.
Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, N.C., USA.
Inflamm Intest Dis. 2016 Apr;1(1):15-23. doi: 10.1159/000443198. Epub 2016 Jan 23.
Cytomegalovirus (CMV) is a ubiquitous human herpes virus, which, after often asymptomatic primary infection, establishes a lifelong latent infection that can periodically be reactivated in both immunocompetent and immunosuppressed carriers. Whereas the diagnostic approach in case of a suspicion of CMV reactivation is well defined, the indication for antiviral therapy can often only be made in the context of an extent of organ involvement, the immune status, and comorbidities of the patient. This article reviews the epidemiology, diagnosis, and therapy of CMV reactivation with a focus on inflammatory bowel diseases and potentially different diagnostic and therapeutic approaches in Asia and the Western world.
巨细胞病毒(CMV)是一种普遍存在的人类疱疹病毒,在通常无症状的初次感染后,会建立终身潜伏感染,这种感染在免疫功能正常和免疫抑制的携带者中都可能周期性地重新激活。虽然怀疑CMV重新激活时的诊断方法已明确界定,但抗病毒治疗的指征往往只能根据器官受累程度、患者的免疫状态和合并症来确定。本文综述了CMV重新激活的流行病学、诊断和治疗,重点关注炎症性肠病以及亚洲和西方世界可能不同的诊断和治疗方法。